azathioprine and everolimus

azathioprine has been researched along with everolimus in 60 studies

Research

Studies (60)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (1.67)	18.2507
2000's	37 (61.67)	29.6817
2010's	21 (35.00)	24.3611
2020's	1 (1.67)	2.80

Authors

Authors	Studies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Alho, H; Harjula, AL; Ikonen, T; Maasilta, P; Salminen, US; Taskinen, E	1
Alho, HS; Harjula, AL; Ikonen, TS; Maasilta, PK; Salminen, US; Taskinen, EI	1
Harjula, AL; Lautenschlager, IT; Maasilta, PK; Salminen, US; Taskinen, EI	1
Ettenger, RB; Grimm, EM	1
Avery, RK	1
Abeywickrama, KH; Bernhardt, P; Dorent, R; Eisen, HJ; Hummel, M; Kobashigawa, J; Lind, JM; Mancini, D; Starling, RC; Sørensen, K; Tuzcu, EM; Valantine-von Kaeppler, HA	1
Dorent, R; Eisen, H; Hsu, CH; Kovarik, JM; Mancini, D; Rordorf, C; Rouilly, M; Vigano, M	1
Banas, B; Böger, C; Krämer, B	1
Azzola, A; Black, J; Chhajed, P; Glanville, A; Havryk, A; Hostettler, K; Johnson, P; Roth, M; Tamm, M	1
Doggrell, SA	1
Eisen, H; Ross, H	1
Dorschner, L; Gallino, A; Ruschitzka, F; Seebach, JD; Speich, R	1
Alho, HS; Maasilta, PK; Päiväniemi, OE; Salminen, US; Wolff, CH	1
Hare, JM; Hauptman, P; Kovarik, JM; Mayer, HW; McCurry, KR; Schmidli, H; Starling, RC	1
Kobashigawa, J; Lindenfeld, J; Lowes, BD; Mestroni, L; Miller, GG; Page, RL; Shakar, SF; Wolfel, EE; Zolty, R	1
Dirks, NL; Huth, B; Meibohm, B; Yates, CR	1
Cantu, E; Cretin, N; Kaló, Z; Kauf, TL; Radeva, JI; Reed, SD; Schulman, KA	1
Valantine, H; Zuckermann, A	1
Valantine, H	1
Bailey, M; Kotsimbos, TC; Law, L; Levvey, BJ; Orsida, B; Snell, GI; Whitford, HM; Williams, TJ; Zheng, L	1
Kovarik, JM; Starling, RC	1
Aris, R; Glanville, AR; Hmissi, A; Loyd, JE; McGiffin, DC; Pirron, U; Roman, A; Snell, GI; Sole, A; Valentine, VG; Vitulo, P	1
Aris, R; Chan, CK; Kovarik, JM; Pirron, U; Schmidli, H; Snell, GI; Valentine, V	1
Calabrese, S; Sparacino, V	1
Eisen, H	1
Chi, NH; Chou, NK; Hsu, RB; Ko, WJ; Tsao, CI; Wang, CH; Wang, SS; Wu, FL	1
Gustafsson, F; Ross, HJ	1
Benavente, D; Buckel, E; Contreras, L; Ferrario, M; Fierro, A; Herzog, C; Morales, J; Zehnder, C	1
Carreño, CA; Gadea, M	1
Abeywickrama, K; Benza, R; Boissonnat, P; Cretin, N; Eisen, HJ; Haverich, A; Hill, J; Laufer, G; Love, R; Parameshwar, J; Pulpón, LA; Renlund, D; Starling, RC; Tuzcu, M; Viganò, M	1
Bailey, M; Kotsimbos, TC; Levvey, BJ; Orsida, B; Snell, GI; Williams, TJ; Zheng, L	1
Snell, GI; Westall, GP	1
Annemans, L; Hetzer, R; Lemkuhl, H; Ricci, JF; Schulz, U; Tenderich, G; Yang, XL	1
Armstrong, VW; Brandhorst, G; Koerfer, R; Oellerich, M; Oezpeker, C; Tenderich, G; Zittermann, A	1
Campbell, S; Chadban, SJ; Chang, SH; McDonald, SP; Russ, GR	1
Alexeeva, O; Feagan, B; Haas, T; Korom, S; Lémann, M; Mayer, H; Mikhailova, T; Panés, J; Reinisch, W; Sanna, L; Schmidt, S; Schreiber, S; Sturniolo, GC	1
de Prada, JA; Exposito, V; Fernández-Friera, L; García-Camarero, T; González-Vílchez, F; Llano, M; Martín-Durán, R; Ruano, J	1
Badiwala, M; Prodger, J; Ramzy, D; Raoa, V; Ross, H; Sheshgiri, R; Tepperman, E	1
Celik, S; Dengler, TJ; Doesch, AO; Ehlermann, P; Frankenstein, L; Katus, HA; Konstandin, M; Kristen, A; Müller, S; Sack, FU	1
Kobashigawa, JA; Patel, JK	1
Arora, S; Aukrust, P; Bendz, B; Bøtker, HE; Eiskjær, H; Ekmehag, B; Gude, E; Gullestad, L; Jansson, K; Mortensen, SA; Saunamaki, K; Sigurdadottir, V; Simonsen, S; Solbu, D; Ueland, T; Wennerblom, B	1
Arizon, JM; Barten, MJ; Dong, G; Eisen, HJ; Kobashigawa, J; Lehmkuhl, H; Pelligrini, C; Ross, H; Wang, SS; Zuckermann, A	1
Bootun, R	1
Bara, C; Delgado, JF; Dengler, T; Dong, G; Junge, G; Kobashigawa, J; Lehmkuhl, HB; Potena, L; Ross, H; Wang, SS; Witte, S	1
Chan, AJ; Lake, JR	1
Hesselink, DA; van Gelder, T; van Schaik, RH	1
Avci, BK; Cakmak, HA; Cosansu, K; Erturk, E; Ikitimur, B; Karadag, B; Ongen, Z; Seyahi, N	1
Montero, N; Pascual, J	1
Larsen, FS; Ytting, H	1
Abe, T; Ichimaru, N; Imamura, R; Kaimori, JY; Kakuta, Y; Kato, T; Nonomura, N; Takahara, S; Yamanaka, K	1
Karam, S; Wali, RK	1
Anglicheau, D; Babinet, F; Caillard, S; Colosio, C; Deslée, G; Dury, S; Essig, M; Etienne, I; Launois, C; Lebargy, F; Merieau, E; Perotin-Collard, JM; Rieu, P; Rivalan, J; Subra, JF; Thervet, E; Toubas, O	1
Thervet, É	1
Cantisán, S; Guirao-Arrabal, E; Redel-Montero, J; Rivero, A; Santos, F; Torre-Cisneros, J; Torre-Giménez, Á; Vaquero, JM; Vidal, E	1
Anderson, R; Bond, M; Coelho, H; Cooper, C; Crathorne, L; Dudley, J; Haasova, M; Huxley, N; Hyde, C; Jones-Hughes, T; Lowe, J; Marks, S; Mujica-Mota, R; Snowsill, T; Varley-Campbell, J	1
Davidson, BR; Guerrero-Misas, M; Gurusamy, KS; Rodríguez-Perálvarez, M; Thorburn, D; Tsochatzis, E	1
Camacho, I; Dave, Y; Eckembrecher, DG; Eckembrecher, FJ; Nouri, K; Patel, S; Shah, H	1

Reviews

17 review(s) available for azathioprine and everolimus

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Safety and efficacy of TOR inhibitors in pediatric renal transplant recipients. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2001, Volume: 38, Issue:4 Suppl 2 Topics: Adolescent; Age Factors; Azathioprine; Child; Child, Preschool; Clinical Trials as Topic; Cyclosporins; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Everolimus; Graft Rejection; Graft Survival; Half-Life; Humans; Immunosuppressive Agents; Intestinal Absorption; Kidney Transplantation; Prednisone; Sirolimus; Treatment Outcome	2001
Optimizing the immunosuppressive regimen in heart transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2004, Volume: 23, Issue:5 Suppl Topics: Adrenal Cortex Hormones; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Dose-Response Relationship, Drug; Everolimus; Heart Diseases; Heart Transplantation; Humans; Immunosuppressive Agents; Mycophenolic Acid; Sirolimus	2004
Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs. Circulation, 2004, Dec-21, Volume: 110, Issue:25 Topics: Administration, Oral; Adrenal Cortex Hormones; Antimetabolites; Azathioprine; Calcineurin Inhibitors; Clinical Trials as Topic; Cyclosporine; Everolimus; Graft Rejection; Growth Inhibitors; Heart Transplantation; Humans; Immunosuppressive Agents; Mycophenolic Acid; Protein Kinase Inhibitors; Protein Kinases; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases; Transplantation, Homologous	2004
Pharmacokinetics of immunosuppressants: a perspective on ethnic differences. International journal of clinical pharmacology and therapeutics, 2004, Volume: 42, Issue:12 Topics: Azathioprine; Black People; Cyclosporine; Cytochrome P-450 Enzyme System; Everolimus; Graft Survival; Humans; Immunosuppressive Agents; Mycophenolic Acid; Organ Transplantation; Randomized Controlled Trials as Topic; Sirolimus; Tacrolimus; White People	2004
From clinical trials to clinical practice: an overview of Certican (everolimus) in heart transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2005, Volume: 24, Issue:4 Suppl Topics: Azathioprine; Clinical Medicine; Clinical Trials as Topic; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Everolimus; Glucocorticoids; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Sirolimus; Transplantation, Homologous	2005
Proliferation signal inhibitors in cardiac transplantation. Current opinion in cardiology, 2007, Volume: 22, Issue:2 Topics: Azathioprine; Calcineurin; Calcineurin Inhibitors; Cell Proliferation; Coronary Artery Disease; Dose-Response Relationship, Drug; Everolimus; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Mycophenolic Acid; Signal Transduction; Sirolimus	2007
Immunosuppression for lung transplantation: evidence to date. Drugs, 2007, Volume: 67, Issue:11 Topics: Administration, Inhalation; Adrenal Cortex Hormones; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Drug Therapy, Combination; Everolimus; Graft Rejection; Humans; Immunosuppressive Agents; Lung Transplantation; Mycophenolic Acid; Sirolimus; Tacrolimus	2007
Surgical biology for the clinician: vascular effects of immunosuppression. Canadian journal of surgery. Journal canadien de chirurgie, 2010, Volume: 53, Issue:1 Topics: Angiotensin-Converting Enzyme Inhibitors; Azathioprine; Cyclosporine; Delayed Graft Function; Endothelium, Vascular; Everolimus; Graft Rejection; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immune Tolerance; Immunosuppressive Agents; Sirolimus; Tacrolimus; Transplantation Immunology	2010
Effects of immunosuppressive therapy on wound healing. International wound journal, 2013, Volume: 10, Issue:1 Topics: Animals; Azathioprine; Cyclosporine; Everolimus; Humans; Immunosuppressive Agents; Mycophenolic Acid; Rats; Sirolimus; Swine; Tacrolimus; Wound Healing; Wounds and Injuries	2013
Immunosuppression in HCV-positive liver-transplant recipients. Current opinion in organ transplantation, 2012, Volume: 17, Issue:6 Topics: Adrenal Cortex Hormones; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antilymphocyte Serum; Azathioprine; Basiliximab; Calcineurin Inhibitors; Clinical Trials as Topic; Cyclosporine; Daclizumab; Everolimus; Hepatitis C; Humans; Immunoglobulin G; Immunosuppression Therapy; Immunosuppressive Agents; Liver Diseases; Liver Transplantation; Mycophenolic Acid; Receptors, Interleukin-2; Recombinant Fusion Proteins; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases	2012
Pharmacogenetics and immunosuppressive drugs in solid organ transplantation. Nature reviews. Nephrology, 2014, Volume: 10, Issue:12 Topics: Azathioprine; Cyclosporine; Drug Monitoring; Everolimus; Evidence-Based Medicine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Organ Transplantation; Pharmacogenetics; Polymorphism, Genetic; Predictive Value of Tests; Sirolimus; Tacrolimus; Transplantation Immunology	2014
Immunosuppression and Post-transplant Hyperglycemia. Current diabetes reviews, 2015, Volume: 11, Issue:3 Topics: Adrenal Cortex Hormones; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus; Everolimus; Graft Rejection; Humans; Hyperglycemia; Immunosuppressive Agents; Mycophenolic Acid; Postoperative Complications; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases; Transplantation	2015
Current State of Immunosuppression: Past, Present, and Future. Critical reviews in eukaryotic gene expression, 2015, Volume: 25, Issue:2 Topics: Abatacept; Alemtuzumab; Animals; Antibodies, Monoclonal, Humanized; Azathioprine; Bone Marrow Transplantation; Calcineurin Inhibitors; Cyclosporine; Disease Models, Animal; Everolimus; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Lung Transplantation; Mycophenolic Acid; Piperidines; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Sirolimus; Tacrolimus	2015
Immunosuppressive therapy for kidney transplantation in children and adolescents: systematic review and economic evaluation. Health technology assessment (Winchester, England), 2016, Volume: 20, Issue:61 Topics: Abatacept; Antibodies, Monoclonal; Antilymphocyte Serum; Azathioprine; Basiliximab; Child; Clinical Trials as Topic; Cost-Benefit Analysis; Drug Therapy, Combination; Everolimus; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Models, Economic; Mycophenolic Acid; Recombinant Fusion Proteins; Sirolimus; Tacrolimus; Technology Assessment, Biomedical	2016
Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis. The Cochrane database of systematic reviews, 2017, Mar-31, Volume: 3 Topics: Adult; Azathioprine; Bayes Theorem; Cyclosporine; Drug Therapy, Combination; Everolimus; Glucocorticoids; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Transplantation; Mycophenolic Acid; Network Meta-Analysis; Odds Ratio; Retreatment; Sirolimus; Tacrolimus; Transplantation Immunology	2017
A review of heart transplant immunosuppressants and nonmelanoma skin cancer. Archives of dermatological research, 2023, Volume: 315, Issue:9 Topics: Azathioprine; Everolimus; Heart Transplantation; Humans; Immunosuppressive Agents; Mycophenolic Acid; Sirolimus; Skin Neoplasms; Tacrolimus	2023

Trials

17 trial(s) available for azathioprine and everolimus

Article	Year
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. The New England journal of medicine, 2003, Aug-28, Volume: 349, Issue:9 Topics: Adult; Aged; Azathioprine; Coronary Disease; Coronary Vessels; Cyclosporine; Cytomegalovirus Infections; Double-Blind Method; Drug Therapy, Combination; Everolimus; Female; Graft Rejection; Heart Transplantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Lipids; Male; Middle Aged; Reoperation; Sirolimus; Transplantation, Homologous; Tunica Intima; Ultrasonography, Interventional	2003
Everolimus in de novo cardiac transplantation: pharmacokinetics, therapeutic range, and influence on cyclosporine exposure. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2003, Volume: 22, Issue:10 Topics: Adrenal Cortex Hormones; Area Under Curve; Azathioprine; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Everolimus; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Safety; Sirolimus	2003
Therapeutic drug monitoring for everolimus in heart transplant recipients based on exposure-effect modeling. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2004, Volume: 4, Issue:12 Topics: Azathioprine; Drug Monitoring; Everolimus; Heart Transplantation; Humans; Immunosuppressive Agents; Metabolic Clearance Rate; Prospective Studies; Reproducibility of Results; Sirolimus	2004
Economic evaluation of everolimus vs. azathioprine at one year after de novo heart transplantation. Clinical transplantation, 2005, Volume: 19, Issue:1 Topics: Azathioprine; Clinical Trials as Topic; Cytomegalovirus Infections; Everolimus; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Prospective Studies; Sirolimus; Treatment Outcome	2005
Everolimus alters the bronchoalveolar lavage and endobronchial biopsy immunologic profile post-human lung transplantation. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2005, Volume: 5, Issue:6 Topics: Anti-Inflammatory Agents; Azathioprine; Bronchoalveolar Lavage; Bronchoscopy; Cytokines; Double-Blind Method; Everolimus; Female; Graft Rejection; Humans; Immunosuppressive Agents; Lung Transplantation; Lymphocyte Count; Male; Middle Aged; Placebos; Postoperative Complications; Prospective Studies; Sirolimus	2005
Everolimus versus azathioprine in maintenance lung transplant recipients: an international, randomized, double-blind clinical trial. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2006, Volume: 6, Issue:1 Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Bronchiolitis Obliterans; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Everolimus; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lung; Lung Transplantation; Male; Middle Aged; Sirolimus; Syndrome	2006
Everolimus in pulmonary transplantation: pharmacokinetics and exposure-response relationships. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2006, Volume: 25, Issue:4 Topics: Adult; Area Under Curve; Azathioprine; Cyclosporine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Drug Therapy, Combination; Everolimus; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Sirolimus; Treatment Outcome	2006
Long-term cardiovascular risk in transplantation--insights from the use of everolimus in heart transplantation. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21 Suppl 3 Topics: Azathioprine; Cardiovascular Diseases; Cyclosporine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Everolimus; Glucocorticoids; Graft Rejection; Heart Transplantation; Hospital Costs; Humans; Immunocompromised Host; Immunosuppressive Agents; Pennsylvania; Postoperative Complications; Risk Factors; Sirolimus; Tunica Intima; Ultrasonography	2006
Influence of everolimus on cyclosporine Neoral pharmacokinetics in Chinese de novo cardiac transplant recipients. Transplantation proceedings, 2006, Volume: 38, Issue:7 Topics: Adult; Azathioprine; China; Cyclosporine; Drug Therapy, Combination; Everolimus; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Sirolimus	2006
Conversion from a calcineurin inhibitor-based immunosuppressive regimen to everolimus in renal transplant recipients: effect on renal function and proteinuria. Transplantation proceedings, 2007, Volume: 39, Issue:3 Topics: Aged; Antibodies, Monoclonal; Antilymphocyte Serum; Azathioprine; Basiliximab; Calcineurin Inhibitors; Cyclosporine; Drug Therapy, Combination; Everolimus; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Proteinuria; Recombinant Fusion Proteins; Sirolimus	2007
Prevention of acute rejection and allograft vasculopathy by everolimus in cardiac transplants recipients: a 24-month analysis. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2007, Volume: 26, Issue:6 Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Cyclosporine; Double-Blind Method; Everolimus; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Function Tests; Middle Aged; Safety; Sirolimus; Transplantation, Homologous; Treatment Outcome	2007
Interleukin-17 and airway inflammation: a longitudinal airway biopsy study after lung transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2007, Volume: 26, Issue:7 Topics: Azathioprine; Biopsy; Bronchoalveolar Lavage; CD4-Positive T-Lymphocytes; Double-Blind Method; Everolimus; Female; Gene Expression Regulation; Graft Rejection; Humans; Immunosuppressive Agents; Interleukin-17; Lung; Lung Transplantation; Male; Middle Aged; Pneumonia; Prospective Studies; Sirolimus	2007
Economic evaluation of everolimus and mycophenolate mofetil versus azathioprine in de novo heart transplantation. Transplantation proceedings, 2007, Volume: 39, Issue:10 Topics: Acute Disease; Adult; Azathioprine; Belgium; Cardiomyopathy, Dilated; Coronary Disease; Cost of Illness; Double-Blind Method; Everolimus; Female; Graft Rejection; Heart Transplantation; Hemodynamics; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Sirolimus; Survival Analysis; Treatment Failure	2007
A multicenter, randomized, double-blind trial of everolimus versus azathioprine and placebo to maintain steroid-induced remission in patients with moderate-to-severe active Crohn's disease. The American journal of gastroenterology, 2008, Volume: 103, Issue:9 Topics: Adolescent; Adult; Aged; Azathioprine; Crohn Disease; Double-Blind Method; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Placebos; Prospective Studies; Sirolimus; Statistics, Nonparametric; Steroids; Treatment Outcome	2008
Effect of everolimus introduction on cardiac allograft vasculopathy--results of a randomized, multicenter trial. Transplantation, 2011, Jul-27, Volume: 92, Issue:2 Topics: Aged; Azathioprine; C-Reactive Protein; Calcineurin Inhibitors; Disease Progression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Everolimus; Female; Follow-Up Studies; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Mycophenolic Acid; Risk Factors; Scandinavian and Nordic Countries; Sirolimus; Ultrasonography, Interventional; Vascular Cell Adhesion Molecule-1; Vascular Diseases; von Willebrand Factor	2011
Impact of de novo everolimus-based immunosuppression on incisional complications in heart transplantation. Transplantation, 2011, Sep-15, Volume: 92, Issue:5 Topics: Adult; Azathioprine; Cyclosporine; Everolimus; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Multivariate Analysis; Mycophenolic Acid; Postoperative Complications; Risk Factors; Sirolimus	2011
Everolimus is associated with a reduced incidence of cytomegalovirus infection following de novo cardiac transplantation. Transplant infectious disease : an official journal of the Transplantation Society, 2013, Volume: 15, Issue:2 Topics: Adolescent; Adult; Aged; Azathioprine; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Drug Therapy, Combination; Everolimus; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Postoperative Complications; Sirolimus; Statistics as Topic	2013

Other Studies

26 other study(ies) available for azathioprine and everolimus

Article	Year
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Effects of rapamycin analogue SDZ RAD on obliterative lesions in a porcine heterotopic bronchial allograft model. Transplantation proceedings, 1998, Volume: 30, Issue:5 Topics: Animals; Azathioprine; Bronchi; Bronchiolitis Obliterans; Cartilage; Cyclosporine; Epithelium; Everolimus; Immunosuppressive Agents; Methylprednisolone; Mucous Membrane; Necrosis; Polyenes; Sirolimus; Swine; Transplantation, Heterotopic; Transplantation, Homologous	1998
Prevention of small airway obliteration in a swine heterotopic lung allograft model. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2000, Volume: 19, Issue:2 Topics: Animals; Azathioprine; Bronchi; Bronchiolitis Obliterans; Disease Models, Animal; Epithelium; Everolimus; Graft Rejection; Immunosuppressive Agents; Lung Transplantation; Postoperative Complications; Sirolimus; Swine; Transplantation, Heterotopic; Transplantation, Homologous	2000
Immune cells and immunosuppression in a porcine bronchial model of obliterative bronchiolitis. Transplantation, 2001, Sep-27, Volume: 72, Issue:6 Topics: Animals; Azathioprine; Bronchi; Bronchiolitis; Cyclosporine; Drug Therapy, Combination; Everolimus; Glucocorticoids; Graft Rejection; Immune System; Immunohistochemistry; Immunosuppression Therapy; Immunosuppressive Agents; Methylprednisolone; Sirolimus; Swine; Time Factors; Transplantation Immunology; Transplantation, Autologous; Transplantation, Homologous	2001
[To further improve transplantation results]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 2002, Volume: 73, Issue:12 Topics: Azathioprine; Cyclosporine; Double-Blind Method; Everolimus; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Liver Transplantation; Monitoring, Physiologic; Multicenter Studies as Topic; Organ Transplantation; Randomized Controlled Trials as Topic; Sirolimus; Treatment Outcome	2002
Cardiac-allograft vasculopathy. The New England journal of medicine, 2003, Aug-28, Volume: 349, Issue:9 Topics: Azathioprine; Coronary Disease; Cytomegalovirus Infections; Drug Therapy, Combination; Everolimus; Heart Transplantation; Humans; Immunosuppressive Agents; Sirolimus	2003
Everolimus in cardiac-transplant recipients. The New England journal of medicine, 2003, Dec-04, Volume: 349, Issue:23 Topics: Azathioprine; Coronary Disease; Coronary Vessels; Everolimus; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Kidney Failure, Chronic; Sirolimus	2003
Everolimus and mycophenolate mofetil are potent inhibitors of fibroblast proliferation after lung transplantation. Transplantation, 2004, Jan-27, Volume: 77, Issue:2 Topics: Adult; Aged; Azathioprine; Bronchi; Bronchiolitis Obliterans; Cell Division; Cells, Cultured; Cyclosporine; Everolimus; Female; Fibroblasts; Humans; Immunosuppressive Agents; Infections; Lung Diseases; Lung Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Sirolimus; Tacrolimus	2004
Is everolimus useful in preventing allograft rejection and vasculopathy after heart transplant? Expert opinion on investigational drugs, 2004, Volume: 13, Issue:2 Topics: Adrenal Cortex Hormones; Aged; Azathioprine; Cholesterol; Cholesterol, LDL; Clinical Trials as Topic; Creatinine; Cyclosporins; Drug Therapy, Combination; Everolimus; Graft Rejection; Heart Transplantation; Humans; Middle Aged; Multicenter Studies as Topic; Peripheral Vascular Diseases; Sirolimus; Transplantation, Homologous	2004
Everolimus-induced drug fever after heart transplantation. Transplantation, 2004, Jul-27, Volume: 78, Issue:2 Topics: Aged; Azathioprine; Cardiomyopathy, Dilated; Drug Therapy, Combination; Everolimus; Fever; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Sirolimus	2004
Cyclooxygenase-2 expression in experimental post-transplant obliterative bronchiolitis. The Journal of pathology, 2004, Volume: 204, Issue:3 Topics: Animals; Azathioprine; Bronchi; Bronchiolitis Obliterans; Chondrocytes; Cyclooxygenase 2; Cyclosporine; Disease Models, Animal; Epithelial Cells; Everolimus; Fibroblasts; Fibrosis; Immunohistochemistry; Immunosuppressive Agents; Isoenzymes; Macrophages; Methylprednisolone; Postoperative Period; Prostaglandin-Endoperoxide Synthases; Sirolimus; Swine	2004
Prevention of cardiac allograft vasculopathy with Certican (everolimus): the Stanford University experience within the Certican Phase III clinical trial. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2005, Volume: 24, Issue:4 Suppl Topics: Adult; Angioplasty, Balloon, Coronary; Azathioprine; Clinical Trials, Phase III as Topic; Coronary Disease; Coronary Vessels; Everolimus; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Sirolimus; Transplantation, Homologous; Tunica Intima; Ultrasonography, Interventional	2005
Therapeutic drug monitoring for everolimus in heart transplant recipients: flawed model or a model for future use? American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2005, Volume: 5, Issue:9 Topics: Azathioprine; Biopsy; Drug Monitoring; Drug Therapy, Combination; Everolimus; Glomerular Filtration Rate; Heart Transplantation; Humans; Immunosuppressive Agents; Metabolic Clearance Rate; Mycophenolic Acid; Retrospective Studies; Sirolimus; Time Factors; Treatment Outcome; Ultrasonography	2005
Conversion to a proliferation signal inhibitor in a patient with coronary artery disease--a case report. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21 Suppl 3 Topics: Angina Pectoris; Angioplasty; Azathioprine; Calcineurin Inhibitors; Cell Proliferation; Cyclosporine; Drug Therapy, Combination; Everolimus; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Postoperative Complications; Signal Transduction; Sirolimus; Treatment Outcome; Withholding Treatment	2006
Case report of a kidney transplant recipient converted to everolimus due to malignancy: resolution of bronchiolitis obliterans organizing pneumonia without everolimus discontinuation. Transplantation proceedings, 2007, Volume: 39, Issue:3 Topics: Adrenal Cortex Hormones; Azathioprine; Cryptogenic Organizing Pneumonia; Cyclosporine; Everolimus; Female; Humans; Kidney Transplantation; Methylprednisolone; Middle Aged; Papillomavirus Infections; Polycystic Kidney Diseases; Postoperative Complications; Sirolimus; Vaginal Neoplasms	2007
Everolimus exposure in cardiac transplant recipients is influenced by concomitant calcineurin inhibitor. Therapeutic drug monitoring, 2008, Volume: 30, Issue:1 Topics: Area Under Curve; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Drug Antagonism; Everolimus; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Sirolimus; Tacrolimus	2008
Trends in adult post-kidney transplant immunosuppressive use in Australia, 1991-2005. Nephrology (Carlton, Vic.), 2008, Volume: 13, Issue:2 Topics: Administration, Oral; Adult; Antibodies; Antimetabolites; Australia; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Everolimus; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Interleukin-2 Receptor alpha Subunit; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; New Zealand; Practice Patterns, Physicians'; Prednisolone; Protein Kinases; Registries; Sirolimus; Steroids; Tacrolimus; Time Factors; TOR Serine-Threonine Kinases	2008
Avoidance of calcineurin inhibitors with use of proliferation signal inhibitors in de novo heart transplantation with renal failure. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2008, Volume: 27, Issue:10 Topics: Administration, Oral; Adrenal Cortex Hormones; Azathioprine; Calcineurin Inhibitors; Cell Division; Everolimus; Glomerular Filtration Rate; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney; Kidney Function Tests; Renal Insufficiency; Retrospective Studies; Sirolimus	2008
Malignancies after heart transplantation: incidence, risk factors, and effects of calcineurin inhibitor withdrawal. Transplantation proceedings, 2010, Volume: 42, Issue:9 Topics: Adolescent; Adult; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Drug Therapy, Combination; Everolimus; Female; Germany; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Mycophenolic Acid; Neoplasms; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Sirolimus; Skin Neoplasms; Survival Rate; Time Factors; TOR Serine-Threonine Kinases; Transplantation, Homologous; Treatment Outcome; Young Adult	2010
Everolimus for cardiac allograft vasculopathy--every patient, at any time? Transplantation, 2011, Jul-27, Volume: 92, Issue:2 Topics: Azathioprine; Calcineurin Inhibitors; Cell Proliferation; Disease Progression; Drug Therapy, Combination; Everolimus; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Muscle, Smooth, Vascular; Mycophenolic Acid; Risk Factors; Sirolimus; Vascular Diseases	2011
Long-Term Impact of Different Immunosuppressive Drugs on QT and PR Intervals in Renal Transplant Patients. Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2015, Volume: 20, Issue:5 Topics: Adult; Arrhythmias, Cardiac; Azathioprine; Cyclosporine; Death, Sudden, Cardiac; Disease Progression; Electrocardiography; Everolimus; Female; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Tacrolimus	2015
Everolimus treatment for patients with autoimmune hepatitis and poor response to standard therapy and drug alternatives in use. Scandinavian journal of gastroenterology, 2015, Volume: 50, Issue:8 Topics: Adrenal Cortex Hormones; Adult; Alanine Transaminase; Azathioprine; Drug Resistance, Multiple; Everolimus; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Function Tests; Male; Middle Aged; Mycophenolic Acid; Remission Induction; Tertiary Care Centers; Treatment Outcome; Young Adult	2015
Risk factors and incidence for lipid abnormalities in kidney transplant patients. Transplantation proceedings, 2015, Volume: 47, Issue:3 Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Azathioprine; Cyclosporine; Dyslipidemias; Everolimus; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Kidney Transplantation; Lipids; Male; Middle Aged; Mycophenolic Acid; Ribonucleosides; Risk Factors; Tacrolimus	2015
Bronchiectasis diagnosed after renal transplantation: a retrospective multicenter study. BMC pulmonary medicine, 2015, Nov-07, Volume: 15 Topics: Adult; Agammaglobulinemia; Aged; Aged, 80 and over; Azathioprine; Bronchiectasis; Chronic Disease; Cough; Cyclosporine; Everolimus; Female; Forced Expiratory Volume; Graft Rejection; Haemophilus Infections; Haemophilus influenzae; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Polycystic Kidney, Autosomal Dominant; Respiratory Tract Infections; Retrospective Studies; Risk Factors; Rituximab; Sirolimus; Tacrolimus; Tomography, X-Ray Computed; Vital Capacity; Young Adult	2015
[Applied pharmacogenetic]. Nephrologie & therapeutique, 2016, Volume: 12 Suppl 1 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Azathioprine; Cyclosporine; Everolimus; Genotype; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Mycophenolic Acid; Neoplasms; Nephrology; Pharmacogenetics; Polymorphism, Genetic; Tacrolimus; Treatment Outcome	2016
Risk of tuberculosis after lung transplantation: the value of pretransplant chest computed tomography and the impact of mTOR inhibitors and azathioprine use. Transplant infectious disease : an official journal of the Transplantation Society, 2016, Volume: 18, Issue:4 Topics: Adolescent; Adult; Aged; Azathioprine; Child; Child, Preschool; Everolimus; Female; Humans; Immunosuppressive Agents; Incidence; Latent Tuberculosis; Lung Transplantation; Male; Middle Aged; Retrospective Studies; Risk Assessment; Risk Factors; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Tuberculin Test; Young Adult	2016